Noriko Hirota
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 4
- Drug Transport and Resistance Mechanisms 4
-
- Pharmacogenetics and Drug Metabolism 4
- Co-authors
- Takafumi Iwatsubo (4 shared papers)Yuichi Sugiyama (4 shared papers)Hiroshi Suzuki (3 shared papers)Tsuyoshi Ooie (2 shared papers)Noriaki Shimada (3 shared papers)Carol E. Green (3 shared papers)Charles A. Tyson (3 shared papers)Kan Chiba (1 shared paper)
- Journals
- Biopharmaceutics & Drug Disposition (2 papers)Pharmacology & Therapeutics (1 paper)Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics (1 paper)Drug Metabolism and Pharmacokinetics (2 papers)Nagasaki University's Academic Output SITE (Nagasaki University) (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Noriko Hirota
7 papers receiving 534 citations
Peers
Comparison fields: 5 of 77
- Pharmacology 387
- Oncology 278
- Computational Theory and Mathematics 82
- Spectroscopy 61
- Pediatrics, Perinatology and Child Health 62
Countries citing papers authored by Noriko Hirota
This map shows the geographic impact of Noriko Hirota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noriko Hirota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noriko Hirota more than expected).
Fields of papers citing papers by Noriko Hirota
This network shows the impact of papers produced by Noriko Hirota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noriko Hirota. The network helps show where Noriko Hirota may publish in the future.
Co-authors
The 21 scholars most cited alongside Noriko Hirota, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 386 | |
| 2 | 1996 | 114 | |
| 3 | 2001 | 59 | |
| 4 | 1998 | 2 | |
| 5 | 2020 | 1 | |
| 6 | Dengue Virus Type 2 Unresponsive to the Current PCR Primer ; Construction of a New PCR Primer to Detect all Strains of Dengue Virus Type 2 | 1995 | 1 |
| 7 | 2014 | 1 | |
| 8 | 1997 | 0 |
About Noriko Hirota
Noriko Hirota is a scholar working on Oncology, Pharmacology, Infectious Diseases, Pharmacology and Cardiology and Cardiovascular Medicine, having authored 8 papers that have together received 564 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Cardiac electrophysiology and arrhythmias (1 paper), Epilepsy research and treatment (1 paper), Mosquito-borne diseases and control (1 paper), Statistical Methods in Clinical Trials (1 paper), Logic, Reasoning, and Knowledge (1 paper) and Liver Disease Diagnosis and Treatment (1 paper). The work is most often cited by research in Pharmacology (387 citations), Oncology (278 citations), Computational Theory and Mathematics (82 citations), Spectroscopy (61 citations) and Pediatrics, Perinatology and Child Health (62 citations). Noriko Hirota has collaborated with scholars based in Japan and United States. Frequent co-authors include Takafumi Iwatsubo, Yuichi Sugiyama, Hiroshi Suzuki, Tsuyoshi Ooie, Noriaki Shimada, Carol E. Green, Charles A. Tyson, Kan Chiba, Takashi Ishizaki and Kiyomi Ito. Their work appears in journals such as Biopharmaceutics & Drug Disposition, Pharmacology & Therapeutics, Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, Drug Metabolism and Pharmacokinetics and Nagasaki University's Academic Output SITE (Nagasaki University).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.